Cargando...

Pharmacogenomics in bladder cancer

Bladder cancer is a common cancer worldwide. For patients presenting with muscle-invasive disease, the five year survival rate is approximately 50%. Cisplatinum-based combination chemotherapy is recommended in the neoadjuvant setting prior to cystectomy and is also the first line in the metastatic s...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Dancik, Garrett M., Theodorescu, Dan
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3904434/
https://ncbi.nlm.nih.gov/pubmed/24360659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2013.09.007
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!